Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07014293

Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

Conditions: Lymphoma

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 254
Sponsor: Massachusetts General Hospital

Location: Mass General Brigham Boston Massachusetts

Summary

The goal of this clinical trial is to learn if a mind body resilience group program can help increase lymphoma survivors' ability to cope with and manage the challenges that come with the transition into early post treatment survivorship.

Eligibility Criteria

Inclusion Criteria: * English speaking adult (18 years or older at enrollment) * At least 6-months post-lymphoma diagnosis and within 2 years of completing active, curative treatment for lymphoma (includes surgery, chemotherapy/immunotherapy/radiation therapy, or other) Exclusion Criteria: * Active Psychiatric or cognitive comorbidity as determined by site PI or treating clinician * Unwilling or unable to participate using telehealth platform

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07014293). StuddyBuddy aggregates publicly available trial information.